Person

Jeffrey Alan Hubbell

This person is no longer with EPFL

About this result

This page is automatically generated and may contain information that is not correct, complete, up-to-date, or relevant to your search query. The same applies to every other page on this website. Please make sure to verify the information with EPFL's official sources.

Ontological neighbourhood

Health sciences

Immunology: Immune system

Infectious diseases: Topics in infectious diseases

Biology

Cell biology: Healing, Cell signaling, Cancer

Chemistry

Organic chemistry: Polymer chemistry, Organic compound

Related publications (299)

Please note that this is not a complete list of this person’s publications. It includes only semantically relevant works. For a full list, please refer to Infoscience.

People doing similar research (19)

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Jeffrey Alan Hubbell

Graph Chatbot

Chat with Graph Search

Targeted antibody and cytokine cancer immunotherapies through collagen affinity

Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes

Targeted antibody and cytokine cancer immunotherapies through collagen affinity

Synthetically glycosylated antigens induce antigen-specific tolerance and prevent the onset of diabetes